Matteo S.
- Country
- Italy
- Department
- Nuclear Medicine and Metabolic Radiotherapy
Research Overview
- Evaluation of [18F]PSMA-1007 PET/CT Imaging for Detecting Pelvic Nodal Metastases in High-Risk Prostate Cancer Patients
- Phase III Study of Lutetium (177Lu) Vipivotide Tetraxetan in PSMA-Positive Oligometastatic Prostate Cancer in Adult Males
- Dosimetry-Based Administration of Sodium Iodide (131I) in Metastatic Differentiated Thyroid Cancer: Efficacy and Toxicity Evaluation
Data & Insights
Has run more than one trial at 19 of 96 partner sites.
Specializations
Thyroid Cancer Research
The investigator specializes in personalized therapy approaches for metastatic thyroid cancer, with particular emphasis on differentiated thyroid carcinoma (DTC) treatment.
- Advanced imaging techniques with 124I PET
- Dosimetry-based treatment optimization
- Molecular characterization of tumor mutations
Their work encompasses comprehensive evaluation of soft tissue and skeletal metastasis response patterns.
Prostate Cancer Management
The investigator focuses on innovative approaches in oligometastatic prostate cancer (OMPC) treatment using advanced therapeutic agents.
- Lutetium-based targeted therapy
- PSMA-positive disease management
- Metastasis progression assessment
Their expertise includes evaluation of disease recurrence patterns and treatment response monitoring.
Advanced Diagnostic Imaging
The investigator specializes in high-precision diagnostic imaging for newly diagnosed prostate cancer cases.
- PSMA PET-CT applications
- Nodal metastasis detection
- High-risk disease assessment
Their work focuses on diagnostic accuracy validation through histological correlation studies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.